Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

1.

The risk of tendon xanthomas in familial hypercholesterolaemia is influenced by variation in genes of the reverse cholesterol transport pathway and the low-density lipoprotein oxidation pathway.

Oosterveer DM, Versmissen J, Yazdanpanah M, Defesche JC, Kastelein JJ, Sijbrands EJ.

Eur Heart J. 2010 Apr;31(8):1007-12. doi: 10.1093/eurheartj/ehp538. Epub 2009 Dec 16.

PMID:
20019024
[PubMed - indexed for MEDLINE]
Free Article
2.

Differences in characteristics and risk of cardiovascular disease in familial hypercholesterolemia patients with and without tendon xanthomas: a systematic review and meta-analysis.

Oosterveer DM, Versmissen J, Yazdanpanah M, Hamza TH, Sijbrands EJ.

Atherosclerosis. 2009 Dec;207(2):311-7. doi: 10.1016/j.atherosclerosis.2009.04.009. Epub 2009 Apr 17. Review.

PMID:
19439299
[PubMed - indexed for MEDLINE]
4.

Tendon xanthomas in familial hypercholesterolemia are associated with cardiovascular risk independently of the low-density lipoprotein receptor gene mutation.

Civeira F, Castillo S, Alonso R, Meriño-Ibarra E, Cenarro A, Artied M, Martín-Fuentes P, Ros E, Pocoví M, Mata P; Spanish Familial Hypercholesterolemia Group.

Arterioscler Thromb Vasc Biol. 2005 Sep;25(9):1960-5. Epub 2005 Jul 14.

PMID:
16020744
[PubMed - indexed for MEDLINE]
Free Article
5.

Unusual xanthomas in a young patient with heterozygous familial hypercholesterolemia and type III hyperlipoproteinemia.

Feussner G, Dobmeyer J, Nissen H, Hansen TS.

Am J Med Genet. 1996 Oct 16;65(2):149-54.

PMID:
8911609
[PubMed - indexed for MEDLINE]
6.

The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.

Jensen HK.

Dan Med Bull. 2002 Nov;49(4):318-45. Review.

PMID:
12553167
[PubMed - indexed for MEDLINE]
7.
8.

5-Lipoxygenase activating protein (ALOX5AP) gene variants associate with the presence of xanthomas in familial hypercholesterolemia.

Oosterveer DM, Versmissen J, Yazdanpanah M, van der Net JB, Defesche JC, Kastelein JJ, Sijbrands EJ.

Atherosclerosis. 2009 Sep;206(1):223-7. doi: 10.1016/j.atherosclerosis.2009.02.019. Epub 2009 Feb 25.

PMID:
19361804
[PubMed - indexed for MEDLINE]
9.

Susceptibility of low density lipoprotein to oxidation in familial hypercholesterolaemia.

Raal FJ, Areias AJ, Waisberg R, von Arb M.

Atherosclerosis. 1995 May;115(1):9-15.

PMID:
7669091
[PubMed - indexed for MEDLINE]
10.

Genetic polymorphism of the apolipoprotein B gene locus influences serum LDL cholesterol level in familial hypercholesterolemia.

Aalto-Setälä K, Gylling H, Helve E, Kovanen P, Miettinen TA, Turtola H, Kontula K.

Hum Genet. 1989 Jul;82(4):305-7.

PMID:
2567693
[PubMed - indexed for MEDLINE]
11.

Overexpression of the CXCL3 gene in response to oxidized low-density lipoprotein is associated with the presence of tendon xanthomas in familial hypercholesterolemia.

Martín-Fuentes P, Civeira F, Solanas-Barca M, García-Otín AL, Jarauta E, Cenarro A.

Biochem Cell Biol. 2009 Jun;87(3):493-8. doi: 10.1139/o09-006.

PMID:
19448742
[PubMed - indexed for MEDLINE]
12.

A xanthomatosis-susceptibility gene may exist in a Syrian family with familial hypercholesterolemia.

Vergopoulos A, Bajari T, Jouma M, Knoblauch H, Aydin A, Bähring S, Mueller-Myhsok B, Dresel A, Joubran R, Luft FC, Schuster H.

Eur J Hum Genet. 1997 Sep-Oct;5(5):315-23.

PMID:
9412789
[PubMed - indexed for MEDLINE]
13.

Impact of genetic defects on atherosclerosis in patients suspected of familial hypercholesterolaemia.

Descamps OS, Gilbeau JP, Leysen X, Van Leuven F, Heller FR.

Eur J Clin Invest. 2001 Nov;31(11):958-65.

PMID:
11737238
[PubMed - indexed for MEDLINE]
14.

Apolipoprotein E genotype is not associated with cardiovascular disease in heterozygous subjects with familial hypercholesterolemia.

Mozas P, Castillo S, Reyes G, Tejedor D, Civeira F, García-Alvarez I, Puzo J, Cenarro A, Alonso R, Mata P, Pocoví M; Spanish group FH.

Am Heart J. 2003 Jun;145(6):999-1005.

PMID:
12796755
[PubMed - indexed for MEDLINE]
15.

Influence of microsomal triglyceride transfer protein promoter polymorphism -493 GT on fasting plasma triglyceride values and interaction with treatment response to atorvastatin in subjects with heterozygous familial hypercholesterolaemia.

García-García AB, González C, Real JT, Martín de Llano JJ, González-Albert V, Civera M, Chaves FJ, Ascaso JF, Carmena R.

Pharmacogenet Genomics. 2005 Apr;15(4):211-8.

PMID:
15864113
[PubMed - indexed for MEDLINE]
16.

CETP (cholesteryl ester transfer protein) promoter -1337 C>T polymorphism protects against coronary atherosclerosis in Japanese patients with heterozygous familial hypercholesterolaemia.

Takata M, Inazu A, Katsuda S, Miwa K, Kawashiri MA, Nohara A, Higashikata T, Kobayashi J, Mabuchi H, Yamagishi M.

Clin Sci (Lond). 2006 Nov;111(5):325-31.

PMID:
16822236
[PubMed - indexed for MEDLINE]
Free Article
17.

Low-density lipoprotein receptor gene mutations and cardiovascular risk in a large genetic cascade screening population.

Umans-Eckenhausen MA, Sijbrands EJ, Kastelein JJ, Defesche JC.

Circulation. 2002 Dec 10;106(24):3031-6.

PMID:
12473547
[PubMed - indexed for MEDLINE]
Free Article
18.

Genotypic and phenotypic variation in familial hypercholesterolemia.

Thompson GR, Seed M, Niththyananthan S, McCarthy S, Thorogood M.

Arteriosclerosis. 1989 Jan-Feb;9(1 Suppl):I75-80.

PMID:
2912434
[PubMed - indexed for MEDLINE]
20.

Mutations of low-density-lipoprotein-receptor gene, variation in plasma cholesterol, and expression of coronary heart disease in homozygous familial hypercholesterolaemia.

Moorjani S, Roy M, Torres A, Bétard C, Gagné C, Lambert M, Brun D, Davignon J, Lupien P.

Lancet. 1993 May 22;341(8856):1303-6.

PMID:
8098448
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk